Article Details

Biohaven Pharmaceutical (BHVN) Given a $63.00 Price Target at Oppenheimer

Retrieved on: 2018-12-18 21:30:00

Tags for this article:

Click the tags to see associated articles and topics

Biohaven Pharmaceutical (BHVN) Given a $63.00 Price Target at Oppenheimer. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new position in shares of Biohaven Pharmaceutical during the third quarter valued at $4,996,000. Finally ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up